How I do it: sequential robot-assisted stereotactic biopsy and laser interstitial thermal therapy for epilepsy associated with brain tumors - Scorecard - MDSpire
Advertisement
How I do it: sequential robot-assisted stereotactic biopsy and laser interstitial thermal therapy for epilepsy associated with brain tumors
Clinical Scorecard: A Stepwise Approach to Robot-Assisted Stereotactic Biopsy and Laser Interstitial Thermal Therapy for Epilepsy Linked to Brain Tumors
At a Glance
Category
Detail
Condition
Drug-resistant focal epilepsy associated with brain tumors
Key Mechanisms
Minimally invasive laser ablation using MR thermometry-guided thermal lesioning combined with robot-assisted stereotactic biopsy
Target Population
Adult and pediatric patients with focal, circumscribed, eloquent, or deep brain lesions including tumors
Care Setting
Neurosurgical operating room with intraoperative CT and MRI suite for real-time monitoring
Key Highlights
LITT produces controlled spheroid-shaped thermal lesions via a 980 nm laser fiber with real-time MR thermometry monitoring.
Robot-assisted stereotactic biopsy enables precise histomolecular diagnosis prior to LITT in deep-seated or difficult-to-access brain tumors.
Thermal barriers such as fissures, sulci, blood vessels, and CSF spaces affect heat diffusion and must be considered during planning.
Guideline-Based Recommendations
Diagnosis
Perform presurgical evaluation including MRI to identify tumor characteristics and epileptogenic focus.
Use robot-assisted stereotactic biopsy with intraoperative histological smear to confirm diagnosis and minimize sample number.
Management
Employ a stepwise approach: first robot-assisted biopsy, then placement of laser fiber for LITT.
Use MR thermometry for real-time temperature monitoring to achieve irreversible thermal ablation at 52 °C threshold.
Plan surgical trajectory considering anatomical thermal barriers and sinks to optimize ablation extent.
Monitoring & Follow-up
Confirm fiber positioning and absence of hemorrhage or air bubbles with T1-weighted MRI post-biopsy.
Monitor ablation zone and brain temperature in real-time using MR thermometry during LITT.
Use diffusion-weighted and T2-FLAIR MRI sequences post-ablation to confirm cytotoxic edema and contrast-enhanced T1 to assess blood–brain barrier disruption.
Risks
Air bubbles from biopsy can cause signal dropout and interfere with MR thermometry monitoring.
Thermal sinks such as blood vessels and CSF spaces may reduce ablation efficacy.
Potential for hemorrhage or tissue damage if trajectory or temperature control is inadequate.
Patient & Prescribing Data
Patients with drug-resistant focal epilepsy linked to deep-seated brain tumors, including dysembryoplastic neuroepithelial tumors
LITT combined with robot-assisted biopsy offers a minimally invasive option when craniotomy is challenging, enabling targeted ablation with histological confirmation.
Clinical Best Practices
Use skull-mounted fiducial markers and intraoperative CT for accurate registration and robotic guidance.
Secure head in Mayfield clamp and use ROSA robotic system for precise instrument alignment.
Perform minimal hair shaving and use progressively smaller reducers for burr hole drilling and dura opening.
Obtain two tissue samples with rapid suction for intraoperative histology to confirm diagnosis.
Calculate and mark catheter length precisely to match target depth minus reducer height.
Advance cooling sheath and secure fiber with guidance bolt before MRI transport.
Monitor for air bubbles and hemorrhage post-biopsy and adjust procedure accordingly.
Deliver multiple adjacent spheroid ablations by retracting fiber to cover entire target volume.
These 10 states make it more practical for physicians to participate in hospital ownership by aligning statutory structure, corporate practice of medicine rules, and population trends.